🔗 Share this article

A shadow economy for unlicensed slimming medications is propelled by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Investigational Treatment Gaining Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to contact these accounts directly for source information, while also obtaining promotional offers.

Active Trade on Social Networks

Separately, a robust market exists on Telegram, where communities with numerous of members share comparison images, injection guides and claims of rapid UK delivery. Vendors market the drug there before redirecting buyers to WhatsApp for transactions.

Learning About The Experimental Drug

This medication is an investigational injectable created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Experts Voice Concerns

Nevertheless, doctors and pharmacists have warned that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could result in individuals injecting products of unknown origin.

Some experts stated the demand for retatrutide could be linked to the increasing cost of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unapproved medication that cannot be promoted or distributed for human use under the British medical regulations.

Some content creators try to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still breach medicines, marketing, and consumer laws, potentially leading to fines, legal action or prison.

Platform Response and Content Removal

According to the social media company, the platform has taken down violative content and banned associated keywords and search suggestions. The company stated it was committed to keeping the platform secure and investing in enhancing compliance measures.

Online Marketplace Activities

Research also discovered communities with up to 9,000 members selling retatrutide using Telegram's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” instantly displays groups with thousands of users, populated with images of slimming results, glowing reviews and step-by-step instructions for mixing or injecting at home.

After moments of entering one community, a vendor shared contact information, where the majority of purchases take place. The seller sent an guidebook and promised delivery within two days. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about body mass, health issues or previous experience.

Product Details and Pricing

Within these groups, posts show black plastic parcels with Royal Mail labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with sterile water, or pre-filled injectors usually priced at 160 pounds for 20mg. When asked how long a injector should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for Telegram stated it regularly moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are injecting materials they cannot confirm. Although the research behind this drug is sound, these digital versions may not include what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.

A medical professional of an online medical service linked the surge in interest to recent price rises for approved slimming drugs such as Mounjaro. “With prices increasing, patients are turning to online platforms. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were produced in was clean,” she said.

Her staff has previously encountered individuals harmed by self-injection from unconfirmed sources. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Statement

A representative from Eli Lilly stated the substance was in third stage research studies and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can market [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company experimental substance not yet approved … may subject users to potentially serious health risks”.